If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPG.L Regulatory News (PPG)

  • There is currently no data for PPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further re Capital Reorganisation

6 Nov 2020 11:00

RNS Number : 5274E
Plutus PowerGen PLC
06 November 2020
 

6 November 2020

PLUTUS POWERGEN PLC

("Plutus", the "Group" or the "Company")

Further re Capital Reorganisation

Further to the announcements released by the Company on 9 October 2020 and 3 November 2020, the Company provides an update on the timetable and process of the Capital Reorganisation. As part of the previously announced Proposals the Company is sub-dividing every Existing Ordinary Share into one New Ordinary Share and nine Deferred Shares.

At the general meeting of the Company held on 3 November 2020, shareholders approved, inter alia, the Capital Reorganisation. Following the passing of the Resolutions the Company's 872,534,994 Existing Ordinary Shares will be sub-divided into one New Ordinary Share of 0.01 pence each and nine Deferred Shares of 0.01 pence each. As announced on 3 November 2020, the Record Date for the Capital Reorganisation is 6.00 p.m. on 6 November 2020.

Application has been made for admission of the 872,534,994 New Ordinary Shares in issue immediately following the Capital Reorganisation to trading on AIM ("Admission"). It is expected that Admission will take place and that trading in the New Ordinary Shares will commence at 8.00 a.m. on 9 November 2020.

Following the Capital Reorganisation and Admission the number of existing ordinary shares in issue, and held by each Shareholder, will not change. It is simply the nominal value of the existing ordinary shares which will change.

The Deferred Shares will have no rights and the Company will not issue any certificates or credit CREST accounts in respect of them. The Deferred Shares will not be admitted to trading on AIM.

As previously announced the Proposals remain conditional on confirmation of the Reduction of Capital by the Court. The Hearing Date to confirm the Reduction of Capital is expected to take place on 24 November 2020 and the Reduction of Capital is expected to become effective between 25 November and 9 December 2020. In particular, the Placing and Debt Capitalisation remain conditional on the Reduction of Capital being confirmed by the Court, the Demerger becoming effective and admission of the Placing Shares and Debt Capitalisation Shares.

A timetable of principal events with regards to the Proposals was set out in the announcement released by the Company on 3 November 2020.

Further announcements will be made in due course.

Definitions in this announcement are consistent with those set out in the circular issued to Shareholders of the Company on 9 October 2020, a copy of which is available on the investor section of the Company's current website (http://www.plutuspowergenplc.com).

For further information, please contact:

Plutus PowerGen PLC

Charles Tatnall, Executive Chairman

James Longley, Interim CEO and Finance Director

 

Tel: +44 (0) 20 8720 6562

 

Allenby Capital (Nominated Adviser and Joint Broker)

Nick Athanas

Nick Naylor

James Hornigold

 

Tel: +44 (0)20 3328 5656

Turner Pope Investments (TPI) Limited (Joint Broker)

Andy Thacker

 

  Tel: +44 (0) 20 3657 0050

St Brides Partners Limited (Financial PR)

Cosima Akerman

Tel: +44 (0)20 7236 1177

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURKKABQKBDDODK
Date   Source Headline
5th Aug 20107:00 amRNSNotice of General Meeting
30th Jul 20107:00 amRNSPreliminary Results 2010
27th Jul 20103:15 pmRNSIssue of Equity
12th Jul 20107:00 amRNSChange of Adviser
25th Jun 20107:00 amRNSTHERAKIND SALE OF INTEREST IN PRODUCT
22nd Jun 20107:00 amRNSIPSO SIGNS COLLABORATION AGREEMENT WITH B1 MEDICAL
12th May 20107:00 amRNSMedermica Files Second Technology Patent
30th Apr 20107:00 amRNSTotal Voting Rights
1st Apr 20109:28 amRNSIssue of New Shares
9th Mar 20107:00 amRNSAXILICA WINS SUBSTANTIAL GRANT
15th Feb 20107:00 amRNSPolyfect enters due diligence agreement
29th Jan 20107:00 amRNSInterim Management Report 2009
14th Jan 20107:00 amRNSIPSol Energy first customer revenues
30th Nov 20097:00 amRNSTotal Voting Rights
6th Nov 200912:19 pmRNSIssue of Shares
6th Nov 200911:39 amRNSDirector's Interest in Shares and Share Options
5th Nov 200910:02 amRNSDirector/PDMR Shareholding
4th Nov 20097:00 amRNSIpso Creates Photovoltaic Testing Business
19th Oct 20097:00 amRNSpH Technology - Development Agreement Signed
15th Oct 20097:00 amRNSTherakind Product Update
11th Sep 20098:42 amRNSResult of AGM
24th Jul 20097:00 amRNSPreliminary Results 2009
8th May 20097:00 amRNSMedermica Files Technology Patent
3rd Apr 20097:00 amRNSSuccessful Fundraising for Therakind
27th Feb 20092:54 pmRNSDirector/PDMR Shareholding
19th Jan 20097:00 amRNSInterim Results
17th Dec 20087:00 amRNSChange of Registered Office
18th Nov 20081:16 pmRNSIssue of New Shares
17th Nov 20084:00 pmRNSAppointment of Joint Broker
4th Nov 20087:00 amRNSAcquisition of Cambridge Meditech
30th Sep 20087:00 amRNSAxilica Limited Update
25th Jul 20087:00 amRNSFinal Results
10th Jul 20087:00 amRNSInvestment in Polyfect Soluti
10th Jan 20087:01 amRNSInterim Results
24th Oct 20072:23 pmRNSAnnual Report and Accounts
25th Sep 20077:00 amRNSInvestment in Axilica
10th Sep 20074:10 pmRNSAdditional Listing
20th Aug 20077:02 amRNSRe: AIM Rule 26
25th Jul 20077:00 amRNSFinal Results
17th Jul 200711:47 amRNSDirector/PDMR Shareholding
5th Jul 20077:01 amRNSFurther investment in IWC
15th Jun 20077:00 amRNSTherakind Investment Update
1st Jun 20077:01 amRNSTotal Voting Rights
23rd May 20072:00 pmRNSIssue of Equity
30th Mar 20075:04 pmRNSTotal Voting Rights
21st Mar 200710:45 amRNSHolding(s) in Company
8th Mar 200711:52 amRNSIssue of Equity
7th Mar 20078:05 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.